Back |

MATTAWAN, MI August 1, 2009:
Register for the opportunity to learn alternative perspectives, network and to gain new insights in the development of novel protein therapeutic biologics. This event is brought to you by MPI Research, in collaboration with MichBio and the Van Andel Institute.

Our speaker panel includes internationally recognized experts who will be presenting the latest information from industry, regulatory, and academic perspectives. Our keynote speaker, Dr. George Vande Woude, will be presenting "MET as a Target in Human Cancer", relating these discoveries to multiple therapeutic areas spanning his career as head of the NCI and Van Andel Institute. Many topics in novel biologics will be addressed over the course of this summit. Registrants will have ample opportunity to interact with summit speakers and co-registrants throughout this event.

Please click below to view the final program for further information on the Novel Therapeutic Biologics: Innovative Molecules and Mechanisms summit. The early-registration rate is valid until August 15, 2009.

MPI Research is committed to partnering with Sponsors to get drugs to the market faster. As a global CRO, the company performs preclinical, early clinical, and select clinical studies for the biotechnology, pharmaceutical, medical device, chemical, agricultural, and animal health industries. Learn more the scope of services available at MPI Research at www.mpiresearch.com or e-mail info@mpiresearch.com.


Home | News